S Greggi — Endo Lab

observational 2025

Endometrioid borderline ovarian tumour: A multicentre analysis from the MITO-14 study

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology ·doi:10.1016/j.ejso.2025.110030

BACKGROUND: The Endometrioid Borderline ovarian tumor (EBOT) is the third most common histological subtype of borderline ovarian tumors. Due to the low incidence of disease, literature is scanty about the prognosis and management of this en…

case-report 1999

Positive response to therapy in a patient with a seropositive paraneoplastic cerebellar degeneration and an endometrioid carcinoma of the vesicovaginal septum

Journal of neurology, neurosurgery, and psychiatry ·doi:10.1136/jnnp.67.3.412

rct 1993

Radical hysterectomy: a randomized study comparing two techniques for resection of the cardinal ligament

Gynecologic Oncology ·doi:10.1006/gyno.1993.1197

To compare two different surgical techniques for the resection of the cardinal ligaments during radical operation for cervical cancer, 84 patients with locally advanced cervical cancer (FIGO stages IB-IIA > or = 4 cm, IIB-III) primarily tre…

other 1990

Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy

Oncology ·doi:10.1159/000226836

Fourteen patients with advanced ovarian carcinoma (FIGO stages III-IV) resistant to cisplatin were submitted to an alternating regimen with doxorubicin (A), cyclophosphamide (C), bleomycin (B) and mitomycin C (M). All patients had measurabl…

other 1988

CA 15-3 as a tumor marker in gynecological malignancies

Gynecologic Oncology ·doi:10.1016/0090-8258(88)90032-7

Serum levels of CA 15-3 were measured in 778 samples from 270 patients with benign and malignant gynecological conditions. Malignant tumors were present in 180 patients including 58 cases with cancer of the ovary, 47 of the endometrium, 61 …